Wudhikarn, K., Pennisi, M., Garcia-Recio, M., Flynn, J. R., Afuye, A., Silverberg, M. L., . . . Perales, M. (2020). DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality. Blood Adv.
Citação norma ChicagoWudhikarn, Kitsada, et al. "DLBCL Patients Treated With CD19 CAR T Cells Experience a High Burden of Organ Toxicities but Low Nonrelapse Mortality." Blood Adv 2020.
Citação norma MLAWudhikarn, Kitsada, et al. "DLBCL Patients Treated With CD19 CAR T Cells Experience a High Burden of Organ Toxicities but Low Nonrelapse Mortality." Blood Adv 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.